Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • IPO Watch: Argenica Therapeutics developing drugs for brain recovery
    • News

    IPO Watch: Argenica Therapeutics developing drugs for brain recovery

    Every 19 minutes someone has a stroke. In 2019 that was 13 million people globally. During a stroke, the lack of oxygen caused by the blockage of blood vessels kills 1.9 million brain cells per minute. The medical interventional methods available to stroke patients are limited and focus on removing the clot chemically or mechanically.

    Read More
    Public
  • Executive Meeting Notes – Are Elon and Tesla on the same page?
    • Opinion

    Executive Meeting Notes – Are Elon and Tesla on the same page?

    We recently had a one-on-one meeting with Mr. Maynard Um (IR Lead) of Tesla Inc (TSLA). The meeting was used as an opportunity to reassess our investment thoughts on the Company and get an update on business operations. During our meeting the official position on the bitcoin investment was one of long-term. However, recent tweets

    Read More
    Public
  • Applyflow sales rise as one-click apply emerges as the future of recruitment
    • News

    Applyflow sales rise as one-click apply emerges as the future of recruitment

    Many graduates lament over the old, clunky and annoying recruitment platforms and job boards that they are forced to trawl in the hopes of getting a foot in the door of their chosen industry. It’s no surprise that 60% of applications get abandoned due to complexity. It’s high time that something newer, streamlined and just

    Read More
    Public
  • Painchek to launch infant pain assessment app in Europe and APAC
    • News

    Painchek to launch infant pain assessment app in Europe and APAC

    Worried parents across Europe and Asia Pacific will soon be able to know when their pre-verbal infants are feeling pain with medtech company PainChek (ASX: PCK) securing regulatory approval for their facial recognition app that assesses pain levels. Where infants cannot communicate their feelings, parents can take a quick smartphone video of the infant’s facial

    Read More
    Public
  • Manganese: the next hot battery metal
    • Opinion

    Manganese: the next hot battery metal

    Move over lithium, graphite, cobalt and copper: manganese is fast emerging as the next ‘battery metal’ story to titillate investors. The back story is similar: with manganese usage dominated by China and supply emanating from largely unattractive or unreliable geographies, western world car and batter makers are desperate to get their paws on the processed

    Read More
    Public
  • Class sweeps tech awards as Australia’s top Wealth Management & SMSF platform
    • News

    Class sweeps tech awards as Australia’s top Wealth Management & SMSF platform

    At a time when digitisation of financial services is being accelerated to improve regulatory compliance, fintech company Class Limited (ASX: CL1) has dominated the Wealth Management & SMSF category at the 2021 the Australian Digital Technology Awards. The awards recognise digital technology companies that provide outstanding outcomes within the financial services industry across Mortgages, Law,

    Read More
    Public
  • «
  • ‹
  • 501
  • 502
  • 503
  • 504
  • 505
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.